Announcements Trials
Browse Landscape

Phase

Phase NA 18Phase 2 6Phase 1 3Phase 3 2Phase 1/2 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Neoplasms, Plasma Cell 2Multiple Myeloma 2cyclopia sequence 1Tobacco Use Cessation 1Prostatic Neoplasms 1Peripheral Nervous System Diseases 1Nocturia 1Myelodysplastic Syndromes 1Lymphoma 1Lung Neoplasms 1Leukemia 1Hodgkin Disease 1Health Education 1Head and Neck Neoplasms 1Fatigue 1Dyspnea 1Carcinoma, Non-Small-Cell Lung 1Bronchiolitis Obliterans Syndrome 1Breast Neoplasms 1Advanced Cancers 1

Interventions

Docetaxel 33Prednisone 28enzalutamide 19Abiraterone Acetate 13pembrolizumab 11gallium 68 PSMA-11 9Leuprolide 9Radiotherapy 8Pluvicto 8Magnetic Resonance Spectroscopy 8Nivolumab 7Estramustine 7abiraterone 6Radiotherapy, Intensity-Modulated 6Goserelin 6Carboplatin 6Biopsy 6olaparib 5cemiplimab 5bicalutamide 5Specimen Handling 5Paclitaxel 5Cyclophosphamide 5temsirolimus 4orteronel 4darolutamide 4cabazitaxel 4acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide 4Sirolimus 4Radiosurgery 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 1/2 × Prostatic Neoplasms × Surveys and Questionnaires × Clear all
NCT05540392 2025-10-10

An Acupuncture Study for Prostate Cancer Survivors With Urinary Issues

Memorial Sloan Kettering Cancer Center

Phase 1/2 Active not recruiting
60 enrolled
Genitourinary

Prostatic Neoplasms, Nocturia

Data powered by HemOnc (CC BY 4.0) Colophon âš¡